Clinical Trial Update: Depot-medroxyprogesterone Acetate (DMPA) Contraceptive Method and Metabolism

View source ↗

Summary

This clinical trial update reports the completion of a study examining the metabolic effects of Depot-medroxyprogesterone acetate (DMPA) contraception, includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Eating Disorders
• Insulin Resistance
• Osteopenia
• Osteoporosis
• Thrombosis

Drugs mentioned

• Depot-medroxyprogesterone acetate (DMPA) (medroxyprogesterone acetate)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Insulin Resistance, Cardiovascular Disease | Status: COMPLETED